Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Opioid Consumption Using Objective Nociceptive Monitoring in Deeply Sedated ICU Patients
2025-521527-74-00Phase 4Authorised
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Jul 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of midazolam, propofol and isoflurane in Neurocritical illness, acute respiratory distress syndrome (ARDS), intracranial hypertension (IH) and 1 more, sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Primary endpoint: Sedation-related physiological and clinical status variables. Planned start Jul 2025; status: authorised.
02
Drugs
midazolampropofolisoflurane
03
Conditions
Neurocritical illnessacute respiratory distress syndrome (ARDS)intracranial hypertension (IH)status epilepticus (SE)
Beyond the preview
Go deeper on 2025-521527-74-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521527-74-00.